Columbia Care Bolsters Presence in Virginia With Third Dispensary Under gLeaf Brand

Columbia Care以gLeaf品牌的第三家药房加强在弗吉尼亚州的存在

2021-11-09 11:57:00 Business Times

本文共6860个字,阅读需18分钟

NEW YORK, Nov. 8, 2021 – PRESS RELEASE – Columbia Care Inc., one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced that it has opened a third dispensary at 11190 West Broad St., in Glen Allen, Va., under the gLeaf brand. “We are pleased to be able to serve the greater Richmond metropolitan area, especially on the heels of the recent addition of whole flower to our product offerings,” Columbia Care CEO Nicholas Vita said. “This dispensary opening marks the next step in our expansion in Virginia to help support the rapidly expanding medical program and its more than 33,000 patients. We are thankful for the support from the Board of Pharmacy and local officials as we continue to grow and evolve.” In the coming months, the company will open two more locations in Carytown and Virginia Beach. Columbia Care and gLeaf are actively developing seven additional dispensaries for a total of 12. Columbia Care is also in the process of rebranding its Portsmouth location as Cannabist, bringing an elevated patient experience to the Hampton Roads area. The company operates 147,765 square feet of cultivation and production space across Virginia, including its 82,000-square-foot indoor cultivation facility, the largest in the commonwealth. The new dispensary includes two drive-thru windows and 12 registers. It will carry gLeaf and Seed & Strain brands, and expects to launch Triple Seven, Classix and other brands, pending regulatory approval. The store is open 9 a.m.-8 p.m. Monday through Saturday and 9 a.m.-7 p.m. on Sunday. For more information, please visit gleaf.com. TALLAHASSEE, Fla., Nov. 8, 2021 – PRESS RELEASE – Trulieve Cannabis Corp., the largest multistate operator (MSO) in the U.S., announced the opening of its first dispensary in West Virginia. Trulieve Morgantown, located at 1397 Earl Core Road, will be the first dispensary in the state to sell medical cannabis. Trulieve will host a ribbon cutting and open its doors to patients at the Morgantown dispensary on Friday, Nov. 12. The company also plans to open its second retail location in Weston, located at 137 Staunton Drive, on Monday, Nov. 15.  West Virginia registered, age-verified patients with a valid medical cannabis card can access Trulieve's diverse product line, including TruFlower, TruClear concentrates, TruSpectrum Whole Plant Extract and Botanical TruPOD cartridges, in addition to a selection of Momenta topicals, capsules and tinctures. Trulieve invites the Morgantown community to join in celebrating the opening of its first West Virginia dispensary. As part of the festivities, patients will receive a 25% in-store discount on opening day and can enjoy free swag giveaways, music, and complimentary food from neighboring Pizza Al's. Those who are not yet registered patients can receive assistance onsite to complete a patient card application on opening day. Trulieve Morgantown will be open from 10 a.m.-6 p.m. Thursday through Saturday, and Trulieve Weston will be open from 10 a.m.-6 p.m. on Monday and Tuesday.  ANNOUNCING: Trulieve Morgantown Ribbon Cutting and Dispensary OpeningWHERE: 1397 Earl Core Rd. Morgantown, WV 26505WHEN: Friday, Nov. 12, 2021, at 9:45 a.m. ANNOUNCING: Trulieve Weston Dispensary OpeningWHERE: 137 Staunton Dr. Weston, WV 26452WHEN: Monday, Nov. 15, 2021, at 10 a.m. "We're thrilled to be first to market in West Virginia and to continue building the foundation for the West Virginia's emerging medical cannabis market," Trulieve CEO Kim Rivers said. "Our team is especially eager to leverage our first-mover advantage to bolster local economies by creating sustainable jobs and investing in marginalized communities. We look forward to serving West Virginia patients, who have been patiently waiting for this day to arrive, with an unparalleled retail experience and the high-quality medical cannabis products they can rely on for safe and effective relief." Trulieve first announced plans to enter West Virginia in February 2021 after securing four dispensary permits from the state's Office of Medical Cannabis. In July, the company became the first MSO to commence cultivation in the state at its 100,000-square-foot Huntington facility. Over the past three months, Trulieve has strategically scaled its cultivation capacity to meet forthcoming patient demand and plans to open more dispensary storefronts across West Virginia in the coming year. As of Nov. 4, the state Department of Health and Human Resources' Office of Medical Cannabis (OMC) had received more than 4,000 patient applications for West Virginia's medical cannabis program.  In advance of commencing medical cannabis sales in the state, Trulieve has established partnerships with community organizations in West Virginia, and looks forward to expanding upon these in the coming months and years. The company participated in several educational and community events this October and will continue its efforts assisting future patients and partnering with health care practitioners around the applications of medical cannabis.  Trulieve's recent and upcoming community engagement events include: For more information on Trulieve's Morgantown and Weston dispensary locations, as well as details on upcoming community engagement events, please visit: https://www.trulieve.com/dispensaries/west-virginia. EDMONTON, Alberta, Nov. 8, 2021 – PRESS RELEASE – Aurora Cannabis Inc., a Canadian company focused on defining the future of cannabinoids worldwide, announced that Aurora Nederland B.V., a wholly owned indirect subsidiary of the company, has entered into an agreement to invest in a significant equity stake in Netherlands-based Growery B.V., one of the few license holders entitled to participate in the controlled cannabis supply chain (CCSC) experiment. The agreement is subject to the regulatory notification procedure. Aurora's investment in Growery is structured such that the company intends to invest an immaterial cash amount of which a portion is due and payable upfront, and the remainder dependent on Growery achieving certain milestones. Under the terms, Aurora will provide a secured loan to Growery to construct a facility, fund early operations and provide technical and operational support through its Netherlands-based, state-of-the-art research facility for medical cannabis, established in 2018. Aurora expects to fully consolidate the revenues realized through the investment into Growery under the applicable International Financial Reporting Standards. "Our investment in Growery is a significant advancement for our global recreational cannabis strategy,” Aurora CEO Miguel Martin said. “The Netherlands is expected to be the largest federally regulated recreational market outside of Canada and is a proof point that our medical market success in Europe is portable to recreational markets. Aurora's global leadership is underscored by a proven track record of regulatory compliance, testing and commitment to science. With similar values and commitment to excellence, we are pleased to be working with Growery to enter the Dutch market." The CCSC is scheduled to be in effect for a minimum of four years, during which the Dutch government will evaluate if the rules of the CCSC should be expanded nationally. Anticipated demand during the CCSC is approximately 30,000 kilograms of dried flower annually. Should the CCSC be expanded nationally (from approximately 80 coffee shops in 10 selected municipalities to the nearly 600 coffee shops that exist today), it is estimated that the Netherlands would require approximately 200,000 kilograms of dried flower annually to fulfill demand. As numerous states have banned delta-8 THC, industry members have debated whether the psychoactive, intoxicating cannabinoid delta-8 THC is a federally controlled substance when derived from hemp. In a Nov. 2 blog post, cannabis and hemp attorney Rod Kight of Kight Law, who has been closely following and commenting on delta-8, highlighted that the U.S. Drug Enforcement Administration (DEA) has clarified in 2021 that hemp-derived delta-8 is not a federally controlled substance. Kight points out in the blog post that in a June virtual town hall meeting, the Florida Department of Agriculture and Consumer Services’ (FDACS) cannabis director, Holly Bell, asked the DEA’s chief of intergovernmental affairs, Sean Mitchell, if delta-8 is federally legal. Mitchell responded: “Sure, and I also want to expand beyond delta-8. There’s delta-8, there’s delta-10, there’s all kind of different cannabinoids associated with Cannabis sativa L. that are kind of out there and making the rounds. So, what I want to say—and I’ll be very deliberate and clear—at this time, I repeat again, at this time—per the [2018] Farm Bill, the only thing that is a controlled substance is delta-9 THC greater than 0.3% based on a dry-weight basis.” Another communication from the DEA that Kight cited in the blog post is a September letter written by Dr. Terrence L. Boos, Ph.D., chief of the DEA’s Drug & Chemical Evaluation Section in its Diversion Control Division. In that letter, addressed to Donna C. Yeatman, R.Ph., executive director of Alabama’s Board of Pharmacy, Boos states that delta-8 THC can be naturally occurring in the cannabis plant or “synthetically produced from non-cannabis materials.” Boos also explains that the Controlled Substances Act (CSA) doesn’t control tetrahydrocannabinols in hemp. Boos writes: “Accordingly, cannabinoids extracted from the cannabis plant that have a D9-THC concentration of not more than 0.3 percent on a dry weight basis meet the definition of ‘hemp’ and thus are not controlled under the CSA.” Hemp Grower recently spoke with Graham Farrar, co-founder, president, board member and chief cannabis officer of vertically integrated high-THC cannabis company Glass House Brands. Farrar is also CEO of SoCal Hemp, a Mojave Desert hemp cannabinoid joint venture between Glass House Brands and natural resources provider Cadiz; that company grew about 50 acres of CBD hemp this year. “I think the fact that [the DEA] came out and said … delta-9 THC can't be higher than 0.3%—it doesn't say anything else—it doesn't say ‘delta-8,’ it doesn't say ‘THC' and leave it broad—it says ‘delta-9 THC’—and so, I think that clarification, at least at the federal level, is really nice to have,” Farrar said. He continued: “Many states have taken a total-THC approach, if you want to use that language, which is THC is THC, and they don’t care about the isomers. And that’s fine—states get to do what they want in this. But it is nice, at least, to know that the federal government's not out there saying, ‘Hey, this is illegal.’ So, I think it’s great to have that clarity because then once you have clarity, you can figure out to do with it.” In another recent interview, Hemp Grower spoke with August Battles, CEO and co-owner of Milwaukee, Wisc., hemp product manufacturer Vance Global. The company started with CBD flower cigarettes and now also sells CBD hemp flower (not rolled), delta-8 flower and cigarettes, and delta-8 gummies, using hemp sourced from Wisconsin and Oregon. Delta-8 is currently the company’s main focus, Battles said. Following the DEA’s recent messaging around delta-8, Battles said he anticipates the delta-8 market will open up more. “We’re realizing you don't want to throw all your eggs in one basket in this industry because it could be like CBD, where it’s hot one minute and then not the next,” he said. “So, you kind of have to jump into every single aspect [of] it.” At face value, solventless processing is a simple concept. You and your team are using heat and pressure in a lab setting to develop a spectrum of concentrated end products for the cannabis consumer.  And while there are many ways to go about that task, there are several commonalities among all successful solventless producers—and several things you’ll want to make sure you avoid along the way. Efficiency is key, says Mallory Tjaden, Marketing Coordinator for PurePressure, and she’s seen how brands of all sizes can save time and money while turning out top-tier products for dispensaries. It’s a delicate and studied process, but the solventless technique provides the full expression of the cannabis plant to consumers, and you’ll want to bear that in mind as you and your team are going about the day-to-day work. DO: Develop a five-year plan with phased rollouts Earning a processing license can be a major challenge in most cannabis markets, so it’s natural that an upstart business team will want to focus all energy on that task. But the brand’s long-term needs are important, right from the jump. With solventless products currently ranking as the fastest-growing concentrates segment in the U.S., your team will want to keep a close eye on short-, mid- and long-term time horizons--and plan accordingly. “You want to know where you want to be eventually,” Tjaden says. “You want to start a lab based on where you think you’ll be--not where you currently are.” This is helpful when seeking investors, too. The market may change, but you’ll have an adaptable roadmap either way. And this is not simply a one-step process from year one to year five; rather, a phase rollout of specific SKUs and brand marketing strategies. What sort of products will you lead with? What products would you like to begin producing and selling in your third year? These are important questions for your timeline. Plus: You’ll save money in the long run by growing into the equipment you buy up front, rather than by incrementally rewriting your business plan each year.  DO: Plan to have a cold room Having a cold room can expand your SKU offerings by providing a cool space to work and store product. You’ll want this room to clock in at around 55°F or lower; your team won’t necessarily need a walk-in freezer to take your product to the next level.  “A cold room can make all of your processes smoother,” Tjaden says. In fact, she adds, it’s imperative in many cases. “If you're working with ice water hash and that's your final product, you really have no choice but to work in a cold room if you want that sandy texture all the way through. You have to keep it cold the entire time. There's really no way around it.” Make sure that you’re planning out the appropriate space for this cold room early in your planning. “If you're going to go through all the trouble of making ice water hash and a live rosin, people really expect a high-quality product and washing in a room-temperature room is one of those ways that you don't get your product across the finish line,” says Eric Vlosky, Director of Marketing and Business Development for PurePressure. Packaging your products in a cold room is even better, and it’s necessary if you are packaging ice water hash in particular. For other SKUs, packaging in a cold room is a helpful example of emerging best practices.  Similar to the five-year plan idea, you’ll want to plan this out in advance. Adding a cold room to your lab once you’ve already started down the road of processing is simply going to cost more. DO: Use RO water and plan for appropriate storage space RO (reverse-osmosis) water and ice are key.  Regular tap water may include invisible elements that can bind to trichomes during the washing process. And even after the water has evaporated, those tiny elements can remain with the product. This is not good. To develop a pure ice water hash product that captures the essence of the plant’s chemistry, clean RO water is needed. The basic ratio involves: ⅓ cannabis, ⅓ ice and ⅓ water (although preferences vary up to ½ ice for some hash makers). Having a dependable storage tank on-site is helpful, too, so that you and your team are not waiting through the RO filtration process when you could be working on the actual cannabis processing.  “Making sure that it's chilled ahead of time really comes down to efficiency,” Vlosky says. “These labs have really demanding production schedules. If you are not ahead of that, if you fall behind … you’re wasting precious time.” It’s a common theme in business, of course, and it’s no different in solventless: Time is money. Efficiency from soup to nuts is critical.  DON’T: Assume solvent-based and solventless processing are one and the same As the cannabis market becomes increasingly normalized in the U.S. and elsewhere, “concentrates” have a tendency to get lumped into one great heap--regardless of the processing technique that created them. Even within the solvent-based category, it’s not super common for retailers or marketers to distinguish between butane, supercritical CO2 or ethanol techniques, never mind the wholesale distinction of a solventless brand. But solvent-based processing techniques and solventless processing techniques are not the same, and it’s a mistake to conflate them in the marketplace. It’s simpler to set up a solventless lab, for one, if only because you and your team won’t need to set up a C1D1-regulated space. Other architectural considerations for solvent-based labs include venting and storage, to say nothing of what the local fire department might want to add.  If you’re getting into solventless, don’t confuse the build-out strategy with what you know about solvent-based labs.  DON’T: Underestimate storage space Already, we’ve mentioned the importance of appropriately sized freezer for storing fresh-frozen material. For labs that are part of a vertically integrated business, this is key. Harvest your plants, and then store the biomass right away. You can also store the ice water hash that your team isn’t using yet. Further along the process, keep in mind the need for small storage spaces elsewhere in the lab, like in your curing area. Make sure your team has a space to store pressed rosin before it makes its way into the next step. And don’t forget about packaging solutions. Pressing and packaging in a separate room that contains boxes and containers and anything needed to get across the finish line. A lot of solventless labs tend to be small, so square footage is already at a premium in the floor plan. It’s easy to overlook requisite storage space, leaving only enough room for a pallet of glass jars, but that’s a problem.  Plan for supply chain issues, too: Your business may need to buy in bulk at times. Where are you going to put everything? All of that storage space also lends itself to a smoother operation in general. Employees will have an easier time navigating the lab when there is ample space to store everything that’s needed (and then some). This will go a long way in saving time and staving off headaches. Remember: Time is money.  DON’T: Disregard ceiling height Maximizing efficiencies in a finite physical space is important; however, many lab startup teams might overlook the importance of ceiling height. This is a two-sided coin, and it’s important to understand what your lab will need from its vertical metrics.  Think about your cold room. If the ceiling is too high, then you’re going to be paying to chill those extra few feet above your team’s heads. You’re throwing money out the window at that point, paying to chill space that you simply aren’t using. “This is a game of inches for a lot of these brands,” Vlosky says. “You're saving money with your utilities and you're being environmentally friendly by using less energy.” It’s all of a piece: Ceiling height will play into decisions made elsewhere in the equipment-purchasing process for your business. “Having a very low ceiling in my cold room, and the opportunity to add in a pneumatic hash pump that eliminated the need for platforms and gravity draining, while not compromising a single trichome’s quality, was integral in my ability to expand and meet our growing demands,” says Jillian Krall, director of hash production at Papa’s Select.  However, in your main lab space, some ceiling height can be good for your workflow. Extra space up top can be helpful if you and your team are hand-washing and gravity-draining, where you’ll want your vessel to be placed on a platform that drains downward. 
纽约,2021年11月8日--新闻稿--哥伦比亚护理公司(Columbia Care Inc.)是美国最大、最有经验的大麻产品种植者、制造商和提供商之一,该公司宣布,已在弗吉尼亚州格伦艾伦的西布罗德街11190号开设了第三家药房,使用gLeaf品牌。 哥伦比亚护理公司首席执行官尼古拉斯·维塔(Nicholas Vita)表示:“我们很高兴能够为大里士满大都市地区提供服务,尤其是在最近我们的产品中增加了整朵花之后。”“药房的开放标志着我们在弗吉尼亚州扩张的下一步,以帮助支持迅速扩大的医疗项目及其33,000多名患者。我们感谢制药董事会和当地官员在我们继续发展和发展的过程中给予的支持。“ 在接下来的几个月里,该公司将在Carytown和弗吉尼亚海滩再开设两个地点。哥伦比亚护理和gLeaf正在积极开发另外七个药房,总数为12个。哥伦比亚护理公司也在将其朴茨茅斯的位置更名为大麻店,为汉普顿路地区带来更高的患者体验。该公司在弗吉尼亚州经营着147,765平方英尺的种植和生产空间,包括其82,000平方英尺的室内种植设施,这是英联邦最大的。 新药房包括两个免下车窗口和12个登记簿。它将携带gLeaf和Seed&Train品牌,并预计将推出Triple Seven、Classix和其他品牌,等待监管机构的批准。这家商店周一至周六上午9点至晚上8点营业,周日上午9点至晚上7点营业。 欲了解更多信息,请访问gleaf.com。 佛罗里达州塔拉哈西,2021年11月8日--新闻稿--美国最大的多州运营商(MSO)Trulieve大麻公司宣布在西弗吉尼亚州开设第一家药房。位于伯爵核心路1397号的Trulieve Morgantown将是该州第一家出售医用大麻的药房。11月12日星期五,Trulieve将在摩根敦药房举办剪彩活动,并向患者敞开大门。该公司还计划于11月15日星期一在韦斯顿开设第二个零售点,位于斯汤顿大道137号。 西弗吉尼亚州注册的、年龄验证的患者持有有效的医用大麻卡,可以获得Trulieve的多种产品线,包括TruFlower、TruClear浓缩物、TruSpectrum全植物提取物和植物TruPOD药筒,以及一系列Momenta外用药、胶囊和酊剂。 Trulieve邀请摩根镇社区加入庆祝其第一个西弗吉尼亚药房的开业。作为庆祝活动的一部分,患者将在开业当天获得25%的店内折扣,并可以享受免费赠品、音乐和邻近比萨饼店的免费食物。尚未登记的患者可在开业当天接受现场协助,完成患者卡的申请。Trulieve Morgantown将于周四至周六上午10点至下午6点开放,Trulieve Weston将于周一和周二上午10点至下午6点开放。 宣布:Trulieve Morgantown剪彩和药房开业地点:伯爵核心路1397号。摩根敦,WV26505,时间:2021年11月12日星期五,上午9:45。 宣布:Trulieve Weston药房开业地点:137 Staunton Weston博士,WV 26452时间:2021年11月15日星期一,上午10点。 Trulieve首席执行官金·里弗斯说:“我们很高兴第一个在西弗吉尼亚州上市,并继续为西弗吉尼亚州新兴的医用大麻市场奠定基础。”“我们的团队特别渴望利用我们的先发优势,通过创造可持续的就业机会和投资边缘化社区来支持当地经济。我们期待着为西弗吉尼亚州的病人服务,他们一直耐心等待这一天的到来,提供无与伦比的零售体验和他们可以依靠的高质量医用大麻产品来安全有效地缓解。” Trulieve在获得该州医用大麻办公室的四份药房许可证后,于2021年2月首次宣布计划进入西弗吉尼亚州。今年7月,该公司成为第一家在该州10万平方英尺的亨廷顿工厂开始种植的MSO。在过去的三个月里,Trulieve已经战略性地扩大了其种植能力,以满足即将到来的患者需求,并计划在未来一年在西弗吉尼亚州开设更多的药房店面。 截至11月4日,州卫生和人力资源部医用大麻办公室(OMC)已收到4000多名西弗吉尼亚州医用大麻计划的患者申请。 在该州开始销售医用大麻之前,Trulieve已经与西弗吉尼亚州的社区组织建立了伙伴关系,并期待在未来几个月和几年内扩大这些伙伴关系。今年10月,该公司参加了几次教育和社区活动,并将继续努力帮助未来的患者,并与医疗保健从业者围绕医用大麻的应用建立伙伴关系。 Trulieve最近和即将举行的社区参与活动包括: 欲了解更多关于Trulieve摩根敦和韦斯顿药房位置的信息,以及即将举行的社区参与活动的细节,请访问:https://www.trulieve.com/prefacaries/West-Virginia。 艾伯塔省埃德蒙顿,2021年11月8日-新闻稿-专注于定义全球大麻素未来的加拿大公司极光大麻公司(Aurora Cannabis Inc.)宣布,该公司的全资间接子公司极光尼德兰B.V.已达成协议,投资于总部位于荷兰的Growery B.V.的大量股权,该公司是少数有权参与受控大麻供应链(CCSC)实验的许可证持有者之一。该协议须遵守监管通知程序。 Aurora对Growery的投资结构使本公司打算投资一笔非重大现金,其中一部分是到期的,并应提前支付,其余取决于Growery实现某些里程碑。根据条款,Aurora将向Growery提供担保贷款,以建设一个设施,资助早期运营,并通过其总部设在荷兰的最先进的医用大麻研究设施提供技术和运营支持,该设施于2018年成立。Aurora预计将根据适用的国际财务报告准则全面合并通过对Growery的投资实现的收入。 Aurora首席执行官米格尔·马丁(Miguel Martin)表示:“我们对Growery的投资是我们全球休闲大麻战略的一个重大进步。”“荷兰预计将是加拿大以外最大的联邦监管休闲市场,这证明了我们在欧洲医疗市场的成功可以移植到休闲市场。Aurora的全球领导地位体现在监管合规、测试和对科学的承诺方面的良好记录。基于类似的价值观和对卓越的承诺,我们很高兴与Growery合作进入荷兰市场。” CCSC计划至少生效四年,在此期间,荷兰政府将评估是否应在全国范围内扩大CCSC的规则。在CCSC期间,预计每年的需求约为30,000公斤干花。如果CCSC在全国范围内扩大(从10个选定城市的大约80家咖啡店增加到目前的近600家咖啡店),估计荷兰每年将需要大约20万公斤干花来满足需求。 由于许多州已经禁止了δ-8四氢大麻酚,行业成员一直在争论这种精神活性、令人陶醉的大麻素δ-8四氢大麻酚从大麻中提取时是否是联邦控制的物质。 在11月2日的一篇博客文章中,一直密切关注并评论delta-8的Kight Law的大麻和大麻律师罗德·基特(Rod Kight)强调,美国缉毒署(DEA)已在2021年澄清,大麻衍生的delta-8不是联邦控制的物质。 Kight在博客文章中指出,在6月份的一次虚拟市政厅会议上,佛罗里达州农业和消费者服务部(FDACS)大麻主任霍利·贝尔(Holly Bell)询问了DEA政府间事务负责人肖恩·米切尔(Sean Mitchell),该委员会是否合法。 米切尔回应道:“当然,我也想扩大到三角洲-8以外。有delta-8,有delta-10,有各种各样不同的大麻素与大麻sativa L有关,这些都在那里四处传播。因此,我想说的是--我会非常深思熟虑和明确--在这个时候,我再次重复,在这个时候--根据[2018年]农业法案,唯一受管制的物质是以干重为基础的δ-9四氢大麻酚大于0.3%。“ Kight在博客文章中引用的另一封来自DEA的通信是Terrence L.Boos博士9月份写的一封信,他是DEA转移控制部门药物和化学评估部门的负责人。在这封写给阿拉巴马州制药委员会执行主任唐娜·C·耶特曼(Donna C.Yeatman)的信中,Boos表示,δ-8四氢大麻酚可以自然存在于大麻植物中,也可以“从非大麻材料中合成生产”。Boos还解释说,《受控物质法》(CSA)不控制大麻中的四氢大麻酚。 Boos写道:“因此,从大麻植物中提取的大麻素,以干重计,D9-THC浓度不超过0.3%,符合‘大麻’的定义,因此不受CSA的控制。” 大麻种植者最近与格雷厄姆·法勒(Graham Farrar)进行了交谈,他是垂直整合的高四氢大麻酚大麻公司玻璃屋品牌(Glass House Brands)的联合创始人、总裁、董事会成员和首席大麻官。法勒也是SoCal Hemp的首席执行官,SoCal Hemp是玻璃屋品牌和自然资源提供商加的斯之间的莫哈韦沙漠大麻大麻素合资企业;这家公司今年种植了大约50英亩的CBD大麻。 法勒说:“我认为,事实上(药品管理局)站出来说……delta-9四氢大麻酚不能高于0.3%--它没有说别的--它没有说'Delta-8',它没有说'THC',而是说'delta-9四氢大麻酚'--所以,我认为至少在联邦一级,澄清是非常好的。” 他继续说道:“如果你想用那种语言,许多州已经采取了总四氢大麻酚的方法,那就是四氢大麻酚就是四氢大麻酚,他们不在乎异构体。这很好--各州可以做他们想做的事情。但至少很高兴知道联邦政府没有在外面说,'嘿,这是非法的。‘所以,我认为有这种清晰的感觉很好,因为一旦你有了清晰的感觉,你就可以找到与之相关的方法。“ 在最近的另一次采访中,大麻种植者采访了威斯康星州密尔沃基的首席执行官兼共同所有者奥古斯特·巴特斯。大麻产品制造商万斯全球。该公司从CBD花香烟开始,现在还销售CBD大麻花(未卷制)、delta-8花和香烟以及delta-8胶,使用来自威斯康星州和俄勒冈州的大麻。Battles说,Delta-8目前是该公司的主要焦点。 在美国药品管理局最近发布了关于德尔塔-8的信息后,巴特斯说,他预计德尔塔-8市场将进一步开放。“我们意识到,在这个行业,你不想把所有的鸡蛋都扔在一个篮子里,因为它可能像CBD,前一分钟很热,下一分钟就不热了,”他说。“所以,你必须跳进它的每一个方面。” 从表面上看,无溶剂加工是一个简单的概念。你和你的团队正在实验室环境中使用热量和压力来为大麻消费者开发一系列浓缩的最终产品。 虽然有许多方法来完成这项任务,但所有成功的无溶剂生产商都有几个共同点--以及在此过程中你要确保避免的几件事。 PurePressure的营销协调员Mallory Tjaden说,效率是关键,她看到了各种规模的品牌如何在为药房生产顶级产品的同时节省时间和金钱。这是一个微妙和经过研究的过程,但无溶剂技术向消费者提供了大麻植物的完整表达,当你和你的团队进行日常工作时,你应该记住这一点。 做:制定一个分阶段实施的五年计划 在大多数大麻市场上,获得加工许可证可能是一个重大挑战,所以一个新贵商业团队很自然会想把所有精力都集中在这项任务上。但从一开始,品牌的长期需求就很重要。由于无溶剂产品目前是美国增长最快的浓缩产品,您的团队将密切关注短期、中期和长期的时间范围,并相应地进行规划。 “你想知道你最终想去哪里,”贾登说。“你想根据你认为自己会在哪里开始一个实验室--而不是你目前在哪里。” 这在寻找投资者时也很有帮助。市场可能会发生变化,但无论哪种情况,你都有一个可适应的路线图。这不是简单的从一年级到五年级的一步到位的过程;相反,一个具体的SKU和品牌营销策略的阶段推出。你们将领导哪种产品?你希望在第三年开始生产和销售什么产品?对于你的时间表来说,这些都是重要的问题。 另外:从长远来看,你可以通过发展你预先购买的设备来节省资金,而不是每年递增地重写你的商业计划。 做:计划有一个冷的房间 拥有一个寒冷的房间可以通过提供一个凉爽的空间来工作和储存产品来扩大您的SKU产品。你会希望这个房间在55华氏度左右或更低的温度下打卡;你的团队不一定需要一个走进式冰箱来把你的产品带到下一个水平。 “一个寒冷的房间可以让你的所有过程更加顺利,”Tjaden说。事实上,她补充说,在许多情况下,这是必要的。“如果你在用冰水散列工作,这是你的最终产品,如果你想要一直用沙子质地,你真的别无选择,只能在寒冷的房间里工作。你必须一直保持寒冷。真的没有办法了。“ 确保你在计划的早期就为这个寒冷的房间规划出了合适的空间。 PurePressure的营销和业务发展总监埃里克·弗洛斯基(Eric Vlosky)表示:“如果你要经历制作冰水杂碎和活松香的所有麻烦,人们真的希望有一个高质量的产品,在室温房间里洗涤是你无法让你的产品越过终点线的方法之一。” 在寒冷的房间里包装你的产品甚至更好,如果你包装冰水杂碎,这是必要的。对于其他SKU来说,在冷藏室中进行包装是新兴最佳实践的一个有帮助的例子。 类似于五年计划的想法,你会想要提前计划好。一旦你已经开始了处理的道路,在你的实验室里增加一个冷藏室只会花费更多。 做:使用反渗透水并规划适当的储存空间 反渗透水和冰是关键。 普通自来水可能包含在洗涤过程中能与毛状体结合的不可见元素。即使在水蒸发后,这些微小的元素仍然留在产品中。这样不好。为了开发一种纯净的冰水散列产品,捕捉植物的化学本质,清洁的反渗透水是必要的。基本比例包括:1/3大麻,1/3冰,1/3水(尽管对一些杂碎制造商来说,偏好最多为冰)。 在现场有一个可靠的储罐也是有帮助的,这样你和你的团队就不会在实际大麻加工过程中等待反渗透过滤过程。 “确保它提前冷却真的取决于效率,”弗洛斯基说。“这些实验室有非常严格的生产时间表。如果你没有走在前面,如果你落后了……你在浪费宝贵的时间。“ 当然,这是商业中的一个常见主题,在《无溶剂》中也没有什么不同:时间就是金钱。效率是至关重要的。 不要:假设溶剂法和无溶剂法是一回事 随着美国和其他地方的大麻市场日益正常化,“浓缩物”有一种被集中在一个大堆中的趋势--不管产生它们的加工技术是什么。即使在溶剂型类别中,零售商或营销人员也不太容易区分丁烷、超临界CO2或乙醇技术,更不用说无溶剂品牌的批发区分了。 但是溶剂型加工技术和无溶剂型加工技术并不相同,市场上把它们混为一谈是错误的。 例如,建立无溶剂实验室更简单,因为你和你的团队不需要建立一个C1D1调节的空间。溶剂型实验室的其他建筑考虑包括通风和存储,更不用说当地消防部门可能想增加什么了。 如果您正在进入无溶剂实验室,不要将构建策略与您对溶剂实验室的了解相混淆。 不要:低估存储空间 我们已经提到了适当大小的冰柜储存新鲜冷冻材料的重要性。对于属于垂直集成业务的实验室来说,这是关键。收获你的植物,然后马上储存生物量。您还可以存储您的团队尚未使用的冰水散列。 在这个过程中,请记住实验室其他地方需要小的存储空间,比如你的固化区。确保你的团队在进入下一步之前有一个空间来储存压松香。 别忘了包装解决方案。压制和包装在一个单独的房间里,里面有盒子和容器以及任何需要通过终点线的东西。许多无溶剂实验室往往很小,所以平面图中的平方英尺已经很高了。很容易忽略必要的存储空间,只留下足够的空间来放一个玻璃瓶托盘,但这是一个问题。 对供应链问题也有计划:你的企业有时可能需要大量购买。你要把所有东西都放在哪里? 所有这些存储空间也有助于总体上更平滑的操作。当有足够的空间存储所需的一切(然后是一些)时,员工在实验室导航将会更容易。这将大大节省时间和避免头痛。记住:时间就是金钱。 不要:忽略天花板高度 在有限的物理空间中最大限度地提高效率是很重要的;然而,许多实验室创业团队可能忽略了天花板高度的重要性。这是一个双面硬币,重要的是要了解你的实验室将需要什么从它的垂直指标。 想想你那冰冷的房间。如果天花板太高,那么你就要付钱来冷却你团队头顶上额外的几英尺。在这一点上,你把钱扔出窗外,付钱给你根本不用的冰冷空间。“对于这些品牌来说,这是一场分寸的游戏,”Vlosky说。“你用水电费省钱,用更少的能源对环境友好。” 这一切都是一件事:天花板的高度将影响到您的企业在设备采购过程中做出的其他决定。 Papa's Select散列生产总监吉利安·克拉尔(Jillian Krall)表示:“在我寒冷的房间里,天花板很低,有机会添加气动散列泵,消除了对平台和重力排水的需求,同时不损害任何一个散列的质量,这是我扩大和满足我们日益增长的需求的能力的一部分。” 然而,在您的主要实验室空间,一些天花板高度可能对您的工作流程有好处。如果你和你的团队正在洗手和重力排水,你会希望你的船只放在一个向下排水的平台上,额外的顶部空间可能会有所帮助。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文